Description
Atazanavir sulfate is a complex organic substance that acts as an HIV protease inhibitor. The protease is essential for the virus in replication. It is characterized by few side effects and a good tolerability. Atazanavir was approved by the FDA in 2003 and by the EU Commission in 2004